90
Views
1
CrossRef citations to date
0
Altmetric
Case Report

Efficacy of denosumab therapy for a 21-year-old woman with Prader-Willi syndrome, osteoporosis and history of fractures: a case report

, , , , , , , & show all
Pages 303-307 | Published online: 25 Feb 2019

References

  • HöybyeCHildingAJacobssonHThorénMMetabolic profile and body composition in adults with Prader-Willi syndrome and severe obesityJ Clin Endocrinol Metab20028783590359712161480
  • SinnemaMMaaskantMAvan Schrojenstein Lantman-de ValkHMJPhysical health problems in adults with Prader-Willi syndromeAm J Med Genet A2011155A92112212421834028
  • ButlerJVWhittingtonJEHollandAJBoerHClarkeDWebbTPrevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based studyDev Med Child Neurol200244424825511995893
  • ButlerMGHaberLMernaughRDecreased bone mineral density in Prader-Willi syndrome: comparison with obese subjectsAm J Med Genet2001103321622211745993
  • KhareMGoldJAWencelMEffect of genetic subtypes and growth hormone treatment on bone mineral density in Prader-Willi syndromeJ Pediatr Endocrinol Metabol201427511518
  • BakkerNEKuppensRJSiemensmaEPBone mineral density in children and adolescents with Prader-Willi syndrome: a longitudinal study during puberty and 9 years of growth hormone treatmentJ Clin Endocrinol Metab201510041609161825668198
  • DiédhiouDCunyTSarrANorou DiopSKleinMWeryhaGEfficacy and safety of denosumab for the treatment of osteoporosis: a systematic reviewAnn Endocrinol2015766650657
  • Prader-Willi Syndrome Association (USA)Osteoporosis Evaluation and Therapy in Prader-Willi SyndromeConsensus statement of the PWSA (USA) Clinical Advisory Board. The gathered view (ISSN 1077-9965)20089437633771
  • KumakiDNakamuraYSuzukiTEfficacy of denosumab for osteoporosis in two patients with adult-onset still’s disease-denosumab efficacy in osteoporotic still’s disease patientsJ Clin Med20187463
  • UeharaMNakamuraYTakahashiJEfficacy of denosumab therapy for neurofibromatosis type I with osteoporosis and history of fractures: a case reportMod Rheumatol Case Rep2018219296
  • IsobeFNakamuraYSuzukiTEffects of denosumab on osteoporosis in three cases with anorexia nervosa and a review of the literatureMod Rheumatol Case Rep201821104106
  • UeharaMNakamuraYTakahashiJEfficacy of denosumab for osteoporosis in three female patients with osteogenesis imperfectaTohoku J Exp Med2017242211512028626166
  • DuranATWilsonKSCastnerDMTuckerJMRubinDAAssociation between physical activity and bone in children with Prader-Willi syndromeJ Pediatr Endocrinol Metab201629781982627159915
  • DonzeSHKuppensRJBakkerNEvan Alfen-van der VeldenJAEMHokken-KoelegaACSBone mineral density in young adults with Prader-Willi syndrome: a randomized, placebo-controlled, crossover GH trialClin Endocrinol2018886806812
  • VasikaranSEastellRBruyèreOMarkers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standardsOsteoporos Int201122239142021184054